Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Paper
  • Published:

Association between past infection with Chlamydia pneumoniae and body mass index, low-density lipoprotein particle size and fasting insulin

Abstract

BACKGROUND: Chlamydia pneumoniae infection has been linked to the development of coronary heart disease (CHD), but its relationship to CHD risk factors is less clear.

OBJECTIVE: To determine the relationship between past infection with C. pneumoniae and risk factors for CHD, including body weight amongst subjects with and without CHD.

METHODS: Antibodies to C. pneumoniae and a range of CHD risk factors were determined in 170 subjects, of whom 43 had recent onset angina. Anthropometric, haemodynamic, lipid and metabolic measurements were obtained and related to antibody status in univariate and multivariate analyses.

RESULTS: IgG seropositive (n=62) did not differ from seronegative subjects in age but were significantly heavier (26.6±0.4 vs 25.5±0.3 kg/m2, P=0.02). The prevalence of seropositivity was similar for subjects with and without CHD and for those with or without hypertension. Subjects with fasting insulin levels greater and those with LDL diameters below the median also had a significantly higher prevalence of seropositivity (45.3 vs 27.3%, P=0.015 and 45.0 vs 29.4%, P=0.045 respectively). However in multivariate analysis only body mass index remained significant (P<0.05). Results were not explained by differences in socio-economic class.

CONCLUSION: Although the study has failed to find a greater prevalence of antibodies to C. pneumoniae amongst subjects with recent onset angina there were associations with a number of cardiovascular risk factors. An increase in body weight appears to underlie these relationships.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Saikku P, Leinonen M, Mattila K, Ekman MR, Nieminen MS, Makela PH, Huttunen JK, Valtonen V . Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction Lancet 1988 ii: 983–986.

    Article  Google Scholar 

  2. Danesh J, Collins R, Peto R . Chronic infections and coronary heart disease: is there a link? Lancet 1997 350: 430–436.

    Article  CAS  Google Scholar 

  3. Quinn T . Does Chlamydia pneumoniae cause coronary heart disease? Curr Opin Infect Dis 1998 11: 301–307.

    Article  CAS  Google Scholar 

  4. Pyorala K, Laakso M, Uusitupa M . Diabetes and atherosclerosis: an epidemiologic view Diabet Metab Rev 1987 3: 463–524.

    Article  CAS  Google Scholar 

  5. Laakso M . Insulin resistance and coronary heart disease Curr Opin Lipidol 1996 7: 217–226.

    Article  CAS  Google Scholar 

  6. Sherrard B, Simpson H, Cameron J, Wahi S, Jennings G, Dart A . LDL particle size in subjects with previously unsuspected coronary heart disease: relationship with other cardiovascular risk markers Atherosclerosis 1996 126: 277–287.

    Article  CAS  Google Scholar 

  7. Hahn DL, Golubjatnikov R . Smoking is a potential confounder of the Chlamydia pneumoniae–coronary artery disease association Arterioscler Thromb 1992 12: 945–947.

    Article  CAS  Google Scholar 

  8. Laurila A, Bloigu A, Nayha S, Hassi J, Leinonen M, Saikku P . Chronic Chlamydia pneumoniae infection is associated with a serum lipid profile known to be a risk factor for atherosclerosis Arterioscler Thromb Vasc Biol 1997 17: 2910–2913.

    Article  CAS  Google Scholar 

  9. Cook PJ, Lip GY, Davies P, Beevers DG, Wise R, Honeybourne D . Chlamydia pneumoniae antibodies in severe essential hypertension Hypertension 1998 31: 589–594.

    Article  CAS  Google Scholar 

  10. Dart AM, Cooper B, Kay SB, Salem H . Relationships between protein C, protein S, von Willebrand factor and euglobulin lysis time and cardiovascular risk factors in subjects with and without coronary heart disease Atherosclerosis 1998 140: 55–64.

    Article  CAS  Google Scholar 

  11. Meade TW, Ruddock V, Stirling Y, Chakrabarti R, Miller GJ . Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study Lancet 1993 342: 1076–1079.

    Article  CAS  Google Scholar 

  12. Ridker PM, Kundsin RB, Stampfer MJ, Poulin S, Hennekens CH . Prospective study of chlamydia pneumoniae IgG seropositivity and risks of future myocardial infarction Circulation 1999 99: 1161–1164.

    Article  CAS  Google Scholar 

  13. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW . C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999 19: 972–978.

    Article  CAS  Google Scholar 

  14. Jedrychowski W, Maugeri U, Flak E, Mroz E, Bianchi I . Predisposition to acute respiratory infections among overweight preadolescent children: an epidemiologic study in Poland Public Health 1998 112: 189–195.

    CAS  PubMed  Google Scholar 

  15. Tanaka S, Inoue S, Isoda F, Waseda M, Ishihara M, Yamakawa T, Sugiyama A, Takamura Y, Okuda K . Impaired immunity in obesity: suppressed but reversible lymphocyte responsiveness Int J Obes Relat Metab Disord 1993 17: 631–636.

    CAS  PubMed  Google Scholar 

  16. Coles KA, Plant AJ, Riley TV, Smith DW, McQuillan BM, Thompson PL . Lack of association between seropositivity to Chlamydia pneumoniae and carotid atherosclerosis Am J Cardiol 1999 84: 825–828.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

It is a pleasure to thank Bridget Cooper, Sally Kay, Luke Robinson, Sonja McBrian and Professor Hatem Salem for help in various aspects of this study. This study was funded by the National Health and Medical Research Council of Australia and the Victorian Health Promotion Foundation.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to AM Dart.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dart, A., Martin, J. & Kay, S. Association between past infection with Chlamydia pneumoniae and body mass index, low-density lipoprotein particle size and fasting insulin. Int J Obes 26, 464–468 (2002). https://doi.org/10.1038/sj.ijo.0801890

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijo.0801890

Keywords

This article is cited by

Search

Quick links